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ABSTRACT We describe a procedure for genomic differ-
ence cloning, a method for isolating sequences present in one
genomic DNA population ("tester") that is absent in another
("driver"). By subtractive hybridization, a large excess of
driver is used to remove sequences common to a biotinylated
tester, enriching the "target" sequences that are unique to the
tester. After repeated subtractive hybridization cycles, tester is
separated from driver by avidin/biotin affinity chromatogra-
phy, and single-stranded target is amplified by the polymerase
chain reaction, rendering it double-stranded and clonable. We
model two situations: the gain of sequences that result from
infection with a pathogen and the loss of sequences that result
from a large hemizygous deletion. We obtain 100- to 700-fold
enrichment of target sequences.
One common and fundamental problem of molecular biology
confronts us when two similar genomes differ and we desire
to understand the difference. One simple form of this problem
can occur when a genome becomes deleted for sequences
present in another due to germ-line mutation, as can happen
in genetic disease (1-3), or due to somatic mutation, as can
happen during the development of cancer (4-6). Differences
can also be acquired by infection with a DNA-based patho-
gen. Methods for identifying and isolating sequences present
in one DNA population that are absent or reduced in another
are called "difference cloning." Methods for difference clon-
ing in cDNA populations have been widely described (7-10).
Only one method for the difference cloning of genomic DNA
is reported in the literature. This method was first described
by Lamar and Palmer (11), who used it to clone sequences
from the Y chromosome. Kunkel et al. (12) used a variation
of this method to clone fragments of the Duchenne muscular
dystrophy (DMD) locus, which becomes deleted in some
afflicted individuals. Clones from other X-chromosome
linked deletions have also been obtained by this method (13).
We describe here another method for genomic difference
cloning that is at least as powerful. Although our method is
not yet sufficiently powerful to isolate and define the small
differences in genomes that would make it enormously useful
as a tool for the study of neoplasia or infectious disease of
viral origin, improvements are possible that could bring our
method into that range. In its present state our method is
useful for the analysis of some genetic diseases and infectious
diseases of unknown origin.
We make frequent use of the following nomenclature. Two
DNA populations that differ are referred to as "tester" and
"driver." Tester contains "target" sequences that are not
present in driver. In the procedure ofLamar and Palmer (11),
target sequences were enriched relative to the remainder of
tester in the following way. Tester DNA was prepared by
cleavage with Sau3A and mixed with an excess amount of
randomly sheared driver DNA. DNAs were melted and
reannealed to high Cot values. Double-stranded DNA (ds-
DNA) was then cloned into the BamHI site of a cloning
vector. In principle, only testerDNA annealed to itselfwould
be clonable into a BamHI site. Neither driver annealed to
itself, nor tester to driver, would be clonable. Thus cloned
material would be enriched in target since it can form duplex
only with itself. The yield of this method is poor, since it
depends upon the slow reannealing of dilute tester to itself,
and the theoretical enrichment cannot exceed the mass ratio
of driver to tester. Yields can be improved through the use of
accelerated annealing conditions, such as the phenol emul-
sion reannealing technique (12-14).
Our procedure utilizes a different form of subtractive
hybridization (see Fig. 1). Tester DNA is specially prepared
(cleaved, biotinylated, and ligated to "template" oligonucle-
otides). Prepared tester is then mixed with an excess of
randomly sheared driver, melted, and annealed. After an-
nealing proceeds to 90% completion for driver, the remaining
single-stranded DNAs (ssDNAs) are isolated. ssDNA will
contain tester that is relatively enriched for target sequences,
since target sequences will not have had time to reanneal.
Unreannealed driver will also be present in great excess. This
procedure is reiterated twice more by the addition of fresh
driver, melting, annealing, and fractionation. Tester highly
enriched in target sequences is then completely separated
from the excess unhybridized driver by the presence of the
biotin group. The resulting tester is amplified by a polymer-
ase chain reaction (PCR) (15) and cloned. Using this proce-
dure we obtain 100- to 700-fold enrichment of target se-
quences. In the following we describe the procedure in detail
and demonstrate its use for two model systems.
MATERIALS AND METHODS
Preparation of Driver and Tester DNA. Purified high mo-
lecular weight DNA serving as driver was sheared by soni-
cation to a size range of 0.5-2.0 kilobase pairs (kbp). The
sheared DNA was size fractionated on a Sepharose 4B
(Pharmacia) column to exclude low molecular weight mate-
rial. Aliquots containing 410 pg of the size-selected driver
were ethanol precipitated and stored at -200C until used.
Tester, derived from high molecular weight placental DNA
mixed with bacteriophage A DNA (New England Biolabs),
was cleaved with Sau3A (New England Biolabs) using the
conditions recommended by the supplier and size fraction-
ated on a Sepharose 4B column. Fractions containing frag-
ments between 300 base pairs (bp) and 2 kbp were pooled and
concentrated by ethanol precipitation. DNA was resus-
pended in TE (1 mM Tris HCI, pH 7.5/1 mM EDTA), 20 ug
of the cleaved tester was added to 30 ,ul of buffer containing
Abbreviations: DMD, Duchenne muscular dystrophy; PCR, poly-
merase chain reaction; dsDNA, double-stranded DNA; ssDNA,
single-stranded DNA; HAP, hydroxylapatite.
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FIG. 1. Flow diagram for genomic difference cloning.
50 mM NaCl, 10 mM Tris HCI (pH 7.5), 10 mM MgCl2, 500
AtM (each) dATP, dGTP, and dCTP, and 20 AM Bio-
12-SS-dUTP (16) (a gift from R. Pergolizzi, North Shore
Hospital), and the Klenow fragment of Escherichia coli
polymerase 1 (5 units, New England Biolabs) was added to fill
in the 5' protruding ends. The blunt-ended and biotinylated
DNA fragments were then ligated to the oligonucleotide
template: 5'-CTTACCATGGTAAG-3'. The oligonucleotides
were synthesized on an Applied Biosystems 380-A DNA
synthesizer and were purified by polyacrylamide gel electro-
phoresis. Oligonucleotides were self-annealed and phospho-
rylated; kinase and ligation reactions (17) were performed in
buffers recommended by suppliers except that dithiothreitol
was omitted to avoid cleavage of the biotin group. Oligonu-
cleotides that ligated together were subsequently monomer-
ized by cleavage at the HindIII site that forms upon self-
ligation. Again, dithiothreitol was omitted in the restriction
enzyme buffer. The free oligonucleotide templates were
removed by refractionation on a Sepharose 4B column. The
fractions containing the tester DNA were pooled, ethanol
precipitated, and resuspended in 10 Al of TE. The DNA
concentration was determined by absorption at 260 nm and
by ethidium bromide staining in agarose gels. The testerDNA
was stored in TE at
-70°C. Tester was stable for about 4
weeks.
Solution Hybridization. Tester and driver DNA were mixed
at a mass ratio of 1:200 to a final concentration of 8.2 mg/mil
of driver. The hybridization was performed in a volume of 50
,l in buffer containing 120 mM sodium phosphate (pH 6.8)
overlaid with mineral oil (Sigma) to avoid evaporation. The
DNA mixture was heat-denatured at 97°C for 10 minfollowed
by annealing in the presence of 0.8 M NaCl at 64°C for 36 hr.
After this time
-90%o of the driver DNA was reannealed to
form dsDNA as determined by fractionation over hydroxyl-
apatite (HAP). The annealing mix was diluted 1:300 in 120
mM sodium phosphate (pH 6.8) and incubated with HAP (1
mg/,ug of DNA; DNA-grade Bio-Gel HTP, Bio-Rad) in a
batch procedure (18) with the following modifications. Incu-
bation of the mix was at 640C for 20 min. ssDNA was
recovered by centrifugation for 15 s at 1500 x g. The
supernatant was collected and recentrifuged at 10,000 X g for
30 s. The volume of the HAP supernatant was reduced by
precipitation of the DNA with glassmilk (Geneclean kit, Bio
101, La Jolla, CA) according to the manufacturer's recom-
mendations. The ssDNA was eluted from the glassmilk in a
volume of 40 Al ofH20 at 650C for 10 min, and subsequently
sodium phosphate (pH 6.8) was added to a final concentration
of 120 mM. This eluate was used to redissolve an aliquot (410
,ug) of the ethanol-precipitated driver. The DNAs were
overlaid with mineral oil and the next round of solution
hybridization was started.
Avidin/Biotin Affinity Chromatography. Following the last
solution hybridization, avidin/biotin affinity chromatogra-
phy was performed (16). The eluate of the glassmilk was
adjusted to 200 mM NaCl/10 mM Tris-HCl, pH 7.5/1 mM
EDTA in a volume of 100 Al, and avidin DN (Vector
Laboratories) was added in excess (1 Ag) to the recovered
ssDNA population. After incubation for 30 min at room
temperature, the mixture was chromatographed on a 100-,l
biotin-cellulose (Pierce) column. The column flow-through
was cycled three times followed by washes with the loading
buffer (see above), loading buffer at pH 8.5, and a buffer
containing 50mM NaCl, 10 mM Tris-HCl (pH 8.5), and 1 mM
EDTA. The latter buffer including 50 mM dithiothreitol and
S ng of high molecular weight carrier DNA per ml was used
to elute the bound DNA in 100-pl fractions.
PCR and Cloning. One-fourth of each of the eluates from
the biotin-cellulose column was subjected to amplification by
PCR (15). The PCR contained, in a volume of 50 ,l, 50 mM
KCI, 10 mM Tris HCl (pH 8.4), 3 mM MgC12, 0.01% gelatin,
200 ,uM (each) dATP, dCTP, dGTP, and dTTP, 100 pmol of
the PCR oligonucleotide primers (synthesized on an Applied
Biosystems 380-A DNA synthesizer), and 1 unit of Thermus
aquaticus (Taq) DNA polymerase (Perkin-Elmer/Cetus).
The PCR primer was 5'-CTTACCATGGTAAGGATC-3'.
The cycling conditions were- 1.5 min of denaturation at 95°C,
3 min of annealing at 55°C, and 7 min of polymerization at
72°C. The cycle was repeated 50 times (Thermocycler, Per-
kin-Elmer/Cetus). The last cycle had an additional extension
at 72°C for 10 min. After phenol extraction and ethanol
precipitation, the amplified material was digested with
Sau3A, fractionated on a Sepharose 4B column to remove
low molecular weight products, concentrated by ethanol
precipitation, and ligated to BamHI-cleaved and alkaline
phosphatase-treated pUC118 vector (19). Competent E. coli
DH5a (20) were transformed with the ligation mix and
selected for ampicillin resistance. Recombinant clones were
picked and analyzed based on the blue/white color distinc-
tion.
General Methods. High molecular weight DNA from hu-
man placenta and from cell lines was isolated as described
(21, 22). Plasmid DNA was isolated by the alkaline lysis
procedure (23). For Southern blotting (24), restriction endo-
nuclease-digested genomic DNA (10 ,g), digested plasmid
DNA, and PCR products (one-fifth of the reaction) were
fractionated on agarose gels. The DNAs were transferred
onto GeneScreenPlus nylon membrane (NEN), using a vac-
uum blotting unit (Vacugene, LKB) for 0.8% gels. A DNA to
be used as a hybridization probe was labeled in vitro using a
nick-translation kit (BRL). 32P-labeled single-strand DNA
probes were prepared from M13 single-strand templates as
described (25). Hybridizations to labeled probes were per-
formed in a volume of 30 ml at 68°C overnight, and hybrid-
ization and washing buffers were as described (26). Autora-
diography was performed at -70°C using Kodak XAR-5 films
and intensifying screens (27). For rehybridization experi-
ments, probes were stripped from the nylon membrane by
incubation in 0.2 M NaOH at 420C for 30 min.
Cell Lines and Human Placenta. The Epstein-Barr virus-
immortalized lymphoid cell line DRL 484 (a gift from T.
Genetics: Wieland et al.
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Caskey, Baylor College) was maintained in RPMI medium
supplemented with 10%o fetal calf serum (GIBCO). The
human-chinese hamster somatic cell hybrids GM06318B,
with a human X chromosome, and GM07297, with human
chromosomes 3 and X, were from the Human Genetic Mutant
Cell Repository (Camden, NJ). The cells were cultured in
Dulbecco's modified Eagle's medium supplemented with
20% fetal calf serum. Two passages before extraction of the
DNA the cells were subjected to selection in hypoxanthine/
aminopterin/thymidine medium. Chinese hamster ovary
cells (a gift from D. Spector, Cold Spring Harbor Laboratory)
were cultured in F12 medium supplemented with 10%o fetal
calf serum. Human placenta of a female newborn (a gift from
S. Chao, North Shore Hospital) was immediately dissected
into small pieces, quickly frozen in liquid nitrogen, and stored
at -700C.
PROTOCOL DESIGN
Preparation of Driver and Tester. High molecular weight
driver DNA is sheared by sonication to an average size of 800
bp. High molecular weight tester DNA is cleaved with Sau3A
and the 5' overhang is filled in with the Klenow fragment of
the E. coli DNA polymerase I in the presence of dATP,
dGTP, dCTP, and Bio-12-SS-dUTP, a biotinylated analog of
dTTP (16). The biotin moiety is linked to the uracil residue by
way of a hydrolyzable disulfide group. The tester is thus flush
ended and labeled with biotin. Next, double-stranded oligo-
nucleotide template treated with polynucleotide kinase is
ligated to tester. The sequence of the oligonucleotide (see
Materials and Methods) is self-complementary. When the
template oligomers ligate to themselves, they form a HindIII
cleavage site. After the ligation of the oligomers to tester, the
reaction mix is cleaved with HindIlI to destroy the products
of oligomer self-ligation. This step is necessary in order that
the subsequent PCR (see below) work efficiently.
Subtractive Hybridizations. Tester and driver are mixed at
a mass ratio of 1:200. The DNA mixture is heat-denatured
and allowed to reanneal until 90%o of driver will have
formed duplex DNA. DNA is then fractionated by HAP. The
single-strand fraction will contain tester sequences enriched
in target and a vast excess ofunreannealed driver DNA. After
the addition of fresh driver DNA, this step is repeated two
more times. Each round of annealing and fractionation can,
in theory, enrich target over the remainder of tester by the
factor 1/(1 - Fi), where Fi is the fraction of driver that
reanneals in the ith cycle (and assuming tester anneals to
driver with the same kinetics as driver). Thus, if driver
achieves 90% reannealing in each of three rounds, target will
be enriched by 1000-fold.
Separation of Tester from Driver. DNA from the subtrac-
tive hybridization steps is heavily contaminated with unre-
annealed driver. To isolate tester from driver, the single-
strand DNA fraction from the third round of annealing is
subjected to biotin/avidin affinity chromatography. This step
reduces the amount of driver by a factor of 104 to 105.
Amplification and Cloning of Target. After the affinity
purification of tester, it is single stranded and present in very
low concentration, due to losses of material occurring at each
step of the procedure. To amplify the product of the proce-
dure and to render it double stranded, we utilize the PCR. A
PCR primer (see Materials and Methods) is added, and DNA
is synthesized for 50 cycles. The PCR primer is complemen-
tary to the template oligonucleotide and in addition contains
the Sau3A cleavage sequence at its 3' end. The product of the
PCR reaction is cleaved by Sau3A and ligated into theE. coli
plasmid vector pUC118. E. coli strain DH5a is transformed
and selected on ampicillin plates containing isopropyl f-
D-thiogalactopyranoside and 5-bromo-4-chloro-3-indolyl /3-
D-galactopyranoside. Recombinant clones are identified by
the blue/white color distinction.
RESULTS
To test our protocol we used two model systems. In the first,
we modeled the gain of information in which a human cell is
infected by a pathogen present at about one copy per cell.
Tester DNA and driver DNA came from the identical human
placenta but bacteriophage A DNA was added to tester as a
known target, in a mass ratio of 1 part per 105. Thus the molar
ratio ofA sequences to unique human sequences in tester was
about 1:1. In the second model system, we chose DNA from
a male patient with DMD (28) as driver. This patient has a
deletion of about one megabase of DNA from the X chro-
mosome. Tester DNA was derived from the placenta of a
female newborn. This system is representative of the case of
loss of information.
Gain of Information. A DNA was added as target at single
copy levels to placental DNA. The same placental DNA
without A was used as driver. Several independent trials were
performed. The PCR product was electrophoresed in agarose
gels and Southern blotted using nick-translated A DNA as
probe. Independent PCR products, even from the same
subtraction, contained a random representation of Sau3A-
cleaved A fragments (Fig. 2). We do not understand this
phenomenon. We also observe a strong preference for the
amplification of smaller A Sau3A fragments. PCR products
were ligated into vector pUC118 and used to transform
DH5a. Approximately 104 recombinant clones were ob-
tained. Several hundred white colonies (i.e., those with
vectors containing inserts) were picked and pooled in groups
of 10. Plasmid DNAs were prepared from these pools,
cleaved to release the insert from the vector, and analyzed by
Southern blotting for the presence of A sequences. From our
results we calculate that we achieved a 300- to 750-fold
enrichment of A sequences in three independent trials (see
Table 1).
Loss of Information. In the second system, tester came
from placental DNA and driver came from Epstein-Barr
virus-immortalized lymphocytes of a patient with DMD. We
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FIG. 2. Independent PCRs from a subtractive hybridization.
Human placental DNA was used as driver and human placental DNA
supplemented with one copy of bacteriophage A per haploid genome
was used as tester (experiment 1 of Table 1). After subtractive
hybridization four independent PCRs were performed. Lanes a1-dl,
ethidium bromide staining of PCR products electrophoresed on 1.5%
agarose gels. Lanes a2-d2, Southern blot of a1-dl using nick-
translated A DNA as a probe. Sizes (bp) are indicated on the left.
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Table 1. Estimates of enrichment for target in independent subtraction hybridization experiments
Complexity of Copies of target
Experiment Target target, kbp per haploid tester Yield* Enrichmentt
1 A 50 1.0 5/400 750
2 A 50 2.0 1/100 300
3 A 50 2.0 1/100 300
3 DMD locus 1000 1.0 2/50 120
*Number of clones with inserts from target/number of recombinant clones examined.
tEnrichment (E) is calculated by formula E = (YCe/RCa), where Y is the yield of target, Ce is the
complexity of haploid tester, R is the number of copies of target per haploid tester, and Ca is the
complexity of target. We assume the haploid human genome to be 3 x 106 kbp.
also added A DNA to tester, at two copies per genome, in
order to independently monitor the degree of enrichment.
The PCR product was again cloned into pUC118 and ana-
lyzed. One hundred recombinant clones were picked. Eighty-
seven contained detectable inserts, ranging in size from 100
to 700 bp. One clone contained A sequences. Fifty clones
were picked and used individually as probes in Southern blots
of cleaved DNA from driver and tester (see Fig. 3). Forty
clones appeared to detect single-copy human DNA. Four
clones detected a more complex pattern of bands, four
detected a diffuse smear or highly repetitive sequences, and
two detected no sequences. Two ofthe 40 clones, with inserts
of 350 and 500 bp, hybridized to tester but failed to hybridize
to DNA from the patient with DMD. These two clones were
then hybridized to a panel of DNAs that included DNA
derived from human-hanoster hybrid cells retaining only the
human chromosome X (Fig. 4). These studies indicate that
the human DNA in these two clones contains sequences
derived from the X chromosome. We therefore conclude that
this DNA was deleted from the DMD locus. We estimate
from these results that the target sequences in tester were
enriched at least 100-fold (see Table 1).
DISCUSSION
We have described a general procedure for genomic differ-
ence cloning and modeled it for two situations: the first in
which one DNA population contains acquired sequences,
and the second in which one DNA population has lost
sequences. In a mathematical sense, both situations are
kb
equivalent. Our protocol employs iteration of cycles of
subtractive hybridization during which a large excess of
driver DNA is used to remove sequences common to the
tester DNA, thereby enriching target sequences unique to
tester. The specific experimental features that make this
approach possible are (i) the use of the PCR procedure to
amplify low yields of target DNA and convert it to a double-
stranded, clonable form and (it) the use of biotinylation of the
tester to facilitate its subsequent separation from driver after
subtractive hybridization.
With this procedure we achieve about 100- to 700-fold
enrichment of target sequences, which is close to the theo-
retical prediction. This degree of enrichment makes our
procedure useful for the analysis of mammalian genomic
DNA when the complexity of the target is on the order of a
few megabases. Such a situation arises when we desire to
isolate sequences lost in large hemizygous or homozygous
deletions or when we desire to obtain probes from tissues
infected with nonviral pathogens. Our procedure should also
be applicable to the problem of small deletions occurring in
organisms of low genomic complexity. Our procedure is not
yet sufficiently powerful to be readily applied to other
problems, such as the cloning of sequences lost from small
homozygous deletions found in some tumor cells, or the
isolation of probes from tissues infected with unknown
viruses.
Several improvements in the basic methodology may be
envisioned. In particular, given an enrichment of target, it
should be possible to exploit the second-order kinetics of
self-annealing to engineer a second stage of purification that
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FIG. 3. Southern blots with candidate target sequences as probes. Southern blots of human placental tester DNA (lanes a, c, e, and g) and
of the DMD cell line DRL484 driver DNA (lanes b, d, f, and h) were performed with candidate target clones as probes. Genomic DNA (10 ,ug)
cleaved with EcoR (lanes a-d and el-h1) and HindIl (lanes e2-h2) was hybridized with 32P-labeled single-strand probes obtained from clones
of the DMD subtraction hybridization library (experiment 3 of Table 1). Lanes a and b and lanes c and d were probed with representative clones
recognizing single-copy sequences in both tester and driver. Lanes e and fwere probed with difference clone p484-67, which hybridizes to tester
DNA (lanes e) only. Lanes g and h were probed with difference clone p484-98, which hybridizes to tester DNA (lanes g) only. The DNA was
separated on 0.8% agarose gels. Sizes (kb) are indicated.
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FIG. 4. Southern blots of human-rodent cell hybrids. 32P-labeled
single-strand probes of the DMD difference clones p484-67 (lanes
a1-c1) and p484-98 (lanes a2-c2) were hybridized to EcoRI-cleaved
DNA (10 ,ug) from the cell lines GM06318B containing only the
human chromosome X (lanes b, and b2) and GM07297 containing the
human chromosomes X and 3 (lanes c1 and c2). DNA from Chinese
hamster ovary (lanes a1 and a2) served as a control. The DNA was
separated on 0.8% agarose gels. Sizes (kb) are indicated on the left.
would further enrich target. The theoretical enrichment for a
procedure based on the velocity of self-annealing is an
additional N fold, where N is the fold enrichment of target
achieved after the subtractive hybridization cycles. The
present obstacle to applying this approach is that the product
from the PCR process appears to be a stochastic sampling of
DNA molecules rather than a uniform amplification of mol-
ecules present in tester prior to PCR (see Fig. 2).
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